🕵️ Edesa Biotech, Inc. ($EDSA)
SEC insider & ownership activity, last 12 months · CIK 1540159 · every row links its SEC filing
Over the last 12 months insiders bought $233K with no open-market selling against it. Nijhawan Pardeep bought $230K (Feb–Mar). Velan Capital Master Fund LP added 6.2% → 6.8%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $233K (9 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Nijhawan Pardeep | 8 | $230K | 0 | – | Mar 10, 2026 |
| Michael J. Brooks | 1 | $3K | 0 | – | Feb 26, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Pardeep Nijhawan | 20.0% | 13D | Jun 16, 2026 | filing ↗ | |
| Pardeep Nijhawan Medicine Professional Corporation | 11.2% | 13D | Jun 16, 2026 | filing ↗ | |
| Velan Capital Investment Management LP | 10.0% | 13D | Feb 26, 2026 | filing ↗ | |
| Velan Capital Management LLC | 10.0% | 13D | Feb 26, 2026 | filing ↗ | |
| Morgan Adam | 10.0% | 13D | Feb 26, 2026 | filing ↗ | |
| Venkataraman Balaji | 10.0% | 13D | Feb 26, 2026 | filing ↗ | |
| Velan Capital Holdings LLC | 9.8% | 13D | Feb 26, 2026 | filing ↗ | |
| Rubric Capital Management LP | 7.7% | 13G | May 15, 2026 | filing ↗ | |
| David Rosen | 7.7% | 13G | May 15, 2026 | filing ↗ | |
| Sirenia Capital Management LP | 7.2% | 13G | May 15, 2026 | filing ↗ | |
| Alex Silverstein | 7.2% | 13G | May 15, 2026 | filing ↗ | |
| Velan Capital Master Fund LP | 6.8% | 13D | Feb 26, 2026 | filing ↗ | |
| Perceptive Advisors LLC | 6.7% | 13G | Mar 16, 2026 | filing ↗ | |
| Joseph Edelman | 6.7% | 13G | Mar 16, 2026 | filing ↗ | |
| Perceptive Life Sciences Master Fund, Ltd. | 6.7% | 13G | Mar 16, 2026 | filing ↗ | |
| Integrated CORE Strategies (US) LLC | 5.4% | 13G | Jun 18, 2026 | filing ↗ | |
| Millennium Management LLC | 5.4% | 13G | Jun 18, 2026 | filing ↗ | |
| Millennium Group Management LLC | 5.4% | 13G | Jun 18, 2026 | filing ↗ | |
| Israel A. Englander | 5.4% | 13G | Jun 18, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jun 10, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 10, 2026 | filing ↗ |
| Other events (8.01) | Jun 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 27, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 27, 2026 | filing ↗ |
| Earnings (2.02) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 13, 2026 | filing ↗ |
| Other events (8.01) | Feb 24, 2026 | filing ↗ |
| Earnings (2.02) | Feb 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 13, 2026 | filing ↗ |
| Other events (8.01) | Dec 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 12, 2025 | filing ↗ |
| Earnings (2.02) | Dec 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 12, 2025 | filing ↗ |
| Other events (8.01) | Oct 28, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 30, 2025 | filing ↗ |
| New financial obligation (2.03) | Sep 30, 2025 | filing ↗ |
| Other events (8.01) | Sep 9, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 9, 2025 | filing ↗ |
| Earnings (2.02) | Aug 8, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 8, 2025 | filing ↗ |